Role of Wnt/β-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients
出版年份 2015 全文链接
标题
Role of Wnt/β-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients
作者
关键词
-
出版物
Acta Orthopaedica
Volume 86, Issue 4, Pages 415-425
出版商
Informa UK Limited
发表日期
2015-03-27
DOI
10.3109/17453674.2015.1033606
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption–formation cycles?
- (2014) R. Sapir-Koren et al. OSTEOPOROSIS INTERNATIONAL
- Wnt Inhibitory Factor 1 Deficiency Uncouples Cartilage and Bone Destruction in Tumor Necrosis Factor α-Mediated Experimental Arthritis
- (2013) Michael Stock et al. ARTHRITIS AND RHEUMATISM
- Paradoxical Sost gene expression response to mechanical unloading in metaphyseal bone
- (2013) Brandon R. Macias et al. BONE
- Sclerostin and DKK1 in Primary Hyperparathyroidism
- (2013) Ombretta Viapiana et al. CALCIFIED TISSUE INTERNATIONAL
- Osteocyte-Driven Bone Remodeling
- (2013) Teresita Bellido CALCIFIED TISSUE INTERNATIONAL
- The relationship between inhibitors of the Wnt signalling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus
- (2013) Agostino Gaudio et al. Diabetes & Vascular Disease Research
- Efficacy of a sclerostin antibody compared to a low dose of PTH on metaphyseal bone healing
- (2013) Fredrik Agholme et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Pathogenesis and Medical Management of Diabetic Charcot Neuroarthropathy
- (2013) Janice V. Mascarenhas et al. MEDICAL CLINICS OF NORTH AMERICA
- Wnt-1—a key player in the regulation of human bone mass?
- (2013) Carol Wilson Nature Reviews Endocrinology
- WNT1 Mutations in Early-Onset Osteoporosis and Osteogenesis Imperfecta
- (2013) Christine M. Laine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications
- (2013) Mette Bjerre SpringerPlus
- Wnt signaling in bone formation and its therapeutic potential for bone diseases
- (2013) Jeong Hwan Kim et al. Therapeutic Advances in Musculoskeletal Disease
- Circulating Sclerostin and Dickkopf-1 (DKK1) in Predialysis Chronic Kidney Disease (CKD): Relationship with Bone Density and Arterial Stiffness
- (2012) S. Thambiah et al. CALCIFIED TISSUE INTERNATIONAL
- Sclerostin Levels Associated with Inhibition of the Wnt/β-Catenin Signaling and Reduced Bone Turnover in Type 2 Diabetes Mellitus
- (2012) Agostino Gaudio et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Serum Sclerostin and Risk of Hip Fracture in Older Caucasian Women
- (2012) Aarthi Arasu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Wnt signaling and orthopedics, an overview
- (2011) Fredrik Agholme et al. Acta Orthopaedica
- The effects of Dickkopf-1 antibody on metaphyseal bone and implant fixation under different loading conditions
- (2011) Fredrik Agholme et al. BONE
- The RANKL/RANK/OPG Signaling Pathway Mediates Medial Arterial Calcification in Diabetic Charcot Neuroarthropathy
- (2011) A. Ndip et al. DIABETES
- Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injury
- (2011) Xiaodong Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Emerging Role of Dickkopf-1 in Bone Biology: Is It the Main Switch Controlling Bone and Joint Remodeling?
- (2011) Dimitrios Daoussis et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Plasma osteoprotegerin concentrations in peripheral sensory neuropathy in Type 1 and Type 2 diabetic patients
- (2010) M. Nybo et al. DIABETIC MEDICINE
- Sclerostin antibody treatment enhances metaphyseal bone healing in rats
- (2010) Fredrik Agholme et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Increased Sclerostin Serum Levels Associated with Bone Formation and Resorption Markers in Patients with Immobilization-Induced Bone Loss
- (2010) Agostino Gaudio et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- OPG/RANK/RANKL signaling system and its significance in nephrology.
- (2009) Katarzyna Klejna et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Increased osteoclastic activity in acute Charcot’s osteoarthopathy: the role of receptor activator of nuclear factor-kappaB ligand
- (2008) G. Mabilleau et al. DIABETOLOGIA
- Plasma Osteoprotegerin Concentrations in Type 2 Diabetic Patients and its Association with Neuropathy
- (2008) H. Terekeci et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- The Causes of the Charcot Syndrome
- (2008) William Jeffcoate Clinics in Podiatric Medicine and Surgery
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started